Glass B - Search Results

1

Refractory or relapsed aggressive B-cell lymphoma failing (R)-CHOP: an analysis of patients treated on the RICOVER-60 trial.

Glass B, Dohm AJ, Truemper LH, Pfreundschuh M, Bleckmann A, Wulf GG, Rosenwald A, Ziepert M, Schmitz N; German High-grade Lymphoma Study Group (DSHNHL). Glass B, et al. Ann Oncol. 2017 Dec 1;28(12):3058-3064. doi: 10.1093/annonc/mdx556. Ann Oncol. 2017. PMID: 29232438 Free article. Clinical Trial.

2

High-dose cytostatic agents in allogeneic bone marrow transplantation: comparison of the engraftment promoting potential.

Gassmann W, Uharek L, Erbersdobler A, Glass B, Wottge HU, Schmitz N, Löffler H, Mueller-Ruchholtz W. Gassmann W, et al. Among authors: glass b. Br J Haematol. 1991 Jul;78(3):310-8. doi: 10.1111/j.1365-2141.1991.tb04442.x. Br J Haematol. 1991. PMID: 1908309

3

High-dose chemotherapy and hematopoietic stem cell rescue in patients with relapsed Hodgkin's disease.

Schmitz N, Glass B, Dreger P, Haferlach T, Horst HA, Ollech-Chwoyka J, Suttorp M, Gassmann W, Löffler H. Schmitz N, et al. Among authors: glass b. Ann Hematol. 1993 May;66(5):251-6. doi: 10.1007/BF01738475. Ann Hematol. 1993. PMID: 8099502

4

Allogeneic peripheral blood progenitor cells: current status and future directions.

Dreger P, Glass B, Uharek L, Schmitz N. Dreger P, et al. Among authors: glass b. J Hematother. 1996 Aug;5(4):331-7. doi: 10.1089/scd.1.1996.5.331. J Hematother. 1996. PMID: 8877708 Review.

5

Allogeneic MHC-mismatched activated natural killer cells administered after bone marrow transplantation provide a strong graft-versus-leukaemia effect in mice.

Zeis M, Uharek L, Glass B, Steinmann J, Dreger P, Gassmann W, Schmitz N. Zeis M, et al. Among authors: glass b. Br J Haematol. 1997 Mar;96(4):757-61. doi: 10.1046/j.1365-2141.1997.d01-2101.x. Br J Haematol. 1997. PMID: 9074419 Free article.

6

Sequential high-dose therapy and autologous stem cell transplantation for treatment of mantle cell lymphoma.

Dreger P, von Neuhoff N, Kuse R, Sonnen R, Glass B, Uharek L, Bartels H, Löffler H, Schmitz N. Dreger P, et al. Among authors: glass b. Ann Oncol. 1997 Apr;8(4):401-3. doi: 10.1023/a:1008251301319. Ann Oncol. 1997. PMID: 9209672 Free article. Clinical Trial.

7

Allogenic transplantation of mobilized peripheral blood progenitor cells: towards tailored cell therapy.

Dreger P, Glass B, Uharek L, Zeis M, Schmitz N. Dreger P, et al. Among authors: glass b. Int J Hematol. 1997 Jul;66(1):1-11. doi: 10.1016/s0925-5710(97)00025-x. Int J Hematol. 1997. PMID: 9220655 Review.

8

Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.

Glass B, Majolino I, Dreger P, Scimè R, Santoro A, Vasta S, Suttorp M, Haferlach T, Schmitz N. Glass B, et al. Bone Marrow Transplant. 1997 Oct;20(7):533-41. doi: 10.1038/sj.bmt.1700934. Bone Marrow Transplant. 1997. PMID: 9337054

9

Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).

Uharek L, Glass B, Zeis M, Dreger P, Steinmann J, Löffler H, Schmitz N. Uharek L, et al. Among authors: glass b. Exp Hematol. 1998 Feb;26(2):93-9. Exp Hematol. 1998. PMID: 9472798

10

Early stem cell transplantation for chronic lymphocytic leukaemia: a chance for cure?

Dreger P, von Neuhoff N, Kuse R, Sonnen R, Glass B, Uharek L, Schoch R, Löffler H, Schmitz N. Dreger P, et al. Among authors: glass b. Br J Cancer. 1998 Jun;77(12):2291-7. doi: 10.1038/bjc.1998.381. Br J Cancer. 1998. PMID: 9649148 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

602 results

Search Page

Filters